전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleStephan Grupp MD PhDPhase 1

PHOX2B PC-CAR T Cells (PHOX2B PC-CAR T Cells)

Refractory Neuroblastoma; Relapsed Neuroblastoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese PLA General HospitalPhase 1

PIN+sintilimab (PIN+sintilimab)

Colorectal Cancer; Adult · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Adult+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Active
CGTLimited DatastalePrecigen, IncPhase 1

PRGN-3005 UltraCAR-T cells (PRGN-3005 UltraCAR-T cells)

Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Changzheng HospitalPhase 1

BRL-302 (PSMA-UCAR T, PSMA-UCAR T (BRL-302))

Metastatic Prostate Cancer; Castration-resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

PTC+Pertuzumab (PTC+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#BreastCancer+2
Trials 1Status Recruiting
AntibodyLimited DatastaleSCRI Development Innovations, L…Phase 1

PTK787/ZK222584 and Bevacizumab (PTK787/ZK222584 and Bevacizumab)

Refractory Malignancy; Advanced Malignancies · FRα

#FR#Antibody#Phase1#monoclonal-antibody#RefractoryMalignancy+2
Trials 1Status Active
AntibodyLimited DatastaleJiangsu HengruiPhase 2

PVE+cTACE+Camrelizumab+Apatinib (PVE+cTACE+Camrelizumab+Apatinib)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Jiangsu
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, PXS-5505 and Atezolizumab and Bevacizumab)

Hepatocellular Carcinoma; Cancer of Liver · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#CancerofLiver+1
Trials 1Status Discontinued
CGTLimited DatastalePinze Lifetechnology Co. Ltd.Phase 1

PZ01 CAR-T cells (PZ01 CAR-T cells)

B-cell Acute Lymphoblastic Leukemia; B-cell Lymphoma · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleAbbVie (prior sponsor, Abbott)Phase 3

Palivizumab (Palivizumab)

Respiratory Syncytial Virus Infection · Respiratory Syncytial Virus Infection

#RespiratorySyncytialVirusInfecti#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleKyntra BioPhase 2

Pamrevlumab (Pamrevlumab)

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis

#IdiopathicPulmonaryFibrosis#Antibody#Phase2#monoclonal-antibody#Kyntra
Trials 1Status Active
CGTLimited DatastaleChinese PLA General HospitalPhase 2

Pan-T booster co-expressing MSLN CAR T cell (Pan-T booster co-expressing MSLN CAR T cell)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib + cetuximab β (Pancreatic cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib +Nimotuzumab (Pancreatic cancer: Tunlametinib +Nimotuzumab)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAmgenPhase 2

ABX-EGF (Panitumumab, Panitumumab (ABX-EGF))

Colorectal Cancer; Non-Small Cell Lung Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Non-SmallCellLungCancer+1
Trials 1Status Active
CGTLimited DatastaleThe Evan FoundationPhase 1

2nd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (2nd generation T cells))

Neuroblastoma; Ganglioneuroblastoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

3rd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells))

Neuroblastoma; Ganglioneuroblastoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleThe Evan FoundationPhase 1

long spacer 2nd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (long spacer 2nd generation T cells))

Neuroblastoma; Ganglioneuroblastoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

79 / 103 pages

← PreviousNext →